Trademark search for:

RIVOCEL

EXPIRED USPTO USPTO

No active United States Patent and Trademark Office (USPTO) registrations found, based on publicly available USPTO trademark records.

Trademark records may change over time. For the most up-to-date trademark status, domain availability, and social handle checks, run a live search.

Live search · Most up-to-date results

Also check across:

USPTO Filing History

Key events recorded for this trademark application

2018-12-21 — Application filed
2018-12-25 — Application filed
2019-01-14 — Application filed
2019-03-18 — Assigned to examiner
2019-03-19 — Suspension letter written
2019-03-19 — Letter of suspension e-mailed
2019-03-19 — Notification of letter of suspension e-mailed
2019-09-25 — Report completed suspension check case still suspended
2020-04-15 — Report completed suspension check case still suspended
2020-10-29 — Report completed suspension check case still suspended
2021-05-14 — Approved for pub - principal register
2021-06-02 — Notification of notice of publication e-mailed
2021-06-22 — Published for opposition
2021-06-22 — Official gazette publication confirmation e-mailed
2021-08-17 — Noa e-mailed - sou required from applicant
2022-03-21 — Application abandoned
2022-03-21 — Application abandoned
2022-03-21 — Final status recorded

Owner Information

Bellicum Pharmaceuticals, Inc.
Houston , TX

Correspondent

JOHN PAUL OLEKSIUK COOLEY LLP
1299 PENNSYLVANIA AVENUE, NW, SUITE 700
WASHINGTON, DC 20004-2400
UNITED STATES

Filing Details

Filing Date:
2018-12-21

Status Date:
2022-03-21

Category:
Pharmaceuticals

Filing Year:
2018

Disclaimer: This page is informational only and does not constitute legal advice. Trademark availability depends on jurisdiction, usage, and legal interpretation.